免疫系统
医学
背向效应
佐剂
免疫疗法
癌症研究
肿瘤微环境
免疫学
放射治疗
免疫原性细胞死亡
癌症
疾病
内科学
作者
Thomas Walle,Rafael Martìnez Monge,Adelheid Cerwenka,Daniel Ajona,Ignacio Melero,Fernando Lecanda
标识
DOI:10.1177/1758834017742575
摘要
Radiotherapy (RT) is currently used in more than 50% of cancer patients during the course of their disease in the curative, adjuvant or palliative setting. RT achieves good local control of tumor growth, conferring DNA damage and impacting tumor vasculature and the immune system. Formerly regarded as a merely immunosuppressive treatment, pre- and clinical observations indicate that the therapeutic effect of RT is partially immune mediated. In some instances, RT synergizes with immunotherapy (IT), through different mechanisms promoting an effective antitumor immune response. Cell death induced by RT is thought to be immunogenic and results in modulation of lymphocyte effector function in the tumor microenvironment promoting local control. Moreover, a systemic immune response can be elicited or modulated to exert effects outside the irradiation field (so called abscopal effects). In this review, we discuss the body of evidence related to RT and its immunogenic potential for the future design of novel combination therapies.
科研通智能强力驱动
Strongly Powered by AbleSci AI